초록 ▼

Compositions and methods of the topical treatment of equine laminitis are disclosed. In particular, combinations of a fast acting nitric oxide (NO) donor, a sustained acting NO donor and an NSAID mixed in a lipid-based carrier are described. The application of such combinations to the affected areas

Compositions and methods of the topical treatment of equine laminitis are disclosed. In particular, combinations of a fast acting nitric oxide (NO) donor, a sustained acting NO donor and an NSAID mixed in a lipid-based carrier are described. The application of such combinations to the affected areas, e.g., the hoofs and surrounding tissues, of an equine afflicted with laminitis provides relief from the debilitating effects of this painful, often life-threatening condition.

대표청구항 ▼

[ What is claimed is:] [1.] A method of ameliorating the adverse effects of equine laminitis comprising topically administering to the affected areas of an equine an effective amount of a fast acting nitric oxide (NO) donor and a slow acting NO donor dispersed in a lipid-based carrier and continuing

[ What is claimed is:] [1.] A method of ameliorating the adverse effects of equine laminitis comprising topically administering to the affected areas of an equine an effective amount of a fast acting nitric oxide (NO) donor and a slow acting NO donor dispersed in a lipid-based carrier and continuing to administer said combination until the equine exhibits signs of recovery, said recovery comprises regaining the ability to stand, improved posture, normal gait, improved appetite, or improved or stabilized organ function.